Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05653635
PHASE2
Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study
Sponsor: Centre Paul Strauss
View on ClinicalTrials.gov
Summary
ReciDOPA is a phase II, single-stage randomized, multicenter, prospective trial assessing the efficacy of an irradiation protocol based on Intensity-modulated radiation therapy with simultaneous-integrated boost guided by FDOPA-PET in patient with recurrent glioblastoma.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
54
Start Date
2026-03-01
Completion Date
2028-09-01
Last Updated
2026-02-04
Healthy Volunteers
No
Conditions
Interventions
RADIATION
Simultaneous-integrated boost with IMRT
Simultaneous-integrated boost guided by FDOPA-PET
Locations (2)
CHRU de Nancy
Nancy, De, France
Centre Paul Strauss
Strasbourg, France